Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and HRCT

NCT00633776 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT00633776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00633776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perforomist Versus Foradil Evaluated by Inspiratory Capacity and HRCT
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Withdrawn
Start date
March 31, 2008
Completion date
January 31, 2009
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, chronic obstructive pulmonary disease, copd, emphysema